Insights

Expert analysis on trends, outlooks, and scenarios in your market and industry.

Filter by market:  EMEA  APAC  LATAM  North America  Global  Healthcare

Asia Pacific healthcare markets will see increasingly divergent performances and priorities in 2022, as some countries […]
healthcare landscape in japan
As the COVID-19 wave retreats and vaccination accelerates, Japan’s healthcare recovery is on track and will […]
With an election scheduled for November, healthcare policy in Chile is on ice as the country […]
South Korea skyline
Supply shortages are complicating the vaccination schedule in South Korea, resulting in depressed demand in 2021. […]
Australia’s relatively successful COVID management strategy is being challenged by supply disruptions and public hesitancy, which […]
Brazil flag and healthcare provider
Governments in Latin America still have not released clear strategies regarding how they will address the […]
Argentina
Policy interventions aimed at expanding healthcare access during the pandemic have resulted in growth across some […]
FrontierView’s Asia Pacific research team is constantly having conversations with our healthcare clients about their growth […]
Asia's healthcare
After confronting a second wave of COVID-19 infections and a deepening global recession, Asia Pacific will […]
Governments across Southeast Asia are confronting surging COVID-19 outbreaks, including in countries that were largely successful at limiting […]
The fallout from the pandemic is beginning to become apparent across issues such as centralized procurement, […]
With policymakers highly focused on the functionality of Latin America healthcare systems amid the pandemic, 2021 […]
healthcare funding image
Many Latin American finance ministries are approving austere healthcare budgets for 2021 as compared to their […]
The COVID-19 pandemic has dramatically accelerated the pace of adoption of telehealth across all of Latin […]
healthcare spending, healthcare reform, healthcare
Saudi Arabia confronts a gradual economic recovery in 2021, which will put persistent pressure on non-COVID-19-related […]